Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 31/12/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 774M | 686M | 644M | 636M | 565M | 519M |
| Cost of revenue | 114M | 118M | 110M | 106M | 112M | 112M |
| Gross profit | 661M | 568M | 534M | 530M | 453M | 407M |
| Research and development | 124M | 120M | 117M | 111M | 116M | 110M |
| Selling, general and administrative | 89M | 74M | 54M | 55M | 53M | 50M |
| Operating expenses | 365M | 347M | 324M | 307M | 338M | 311M |
| Operating income | 296M | 221M | 210M | 223M | 116M | 96M |
| Interest expense | 15M | 17M | 18M | 20M | 22M | 28M |
| Pre-tax income | 747M | 203M | 194M | 205M | 93M | 67M |
| Income tax | 156M | 36M | 52M | 43M | 11M | −2M |
| Net income | 591M | 167M | 141M | 163M | 82M | 69M |
| Earnings per share | 5.00 | 1.40 | 1.18 | 1.35 | 0.68 | 0.58 |
| Earnings per share, diluted | 4.98 | 1.39 | 1.17 | 1.35 | 0.68 | 0.57 |
| Weighted average shares | 118M | 119M | 120M | 120M | 120M | 120M |
| Weighted average shares, diluted | 119M | 120M | 120M | 121M | 121M | 121M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 439M | 210M | 184M | 199M | 235M | 197M | 266M | 248M |
| Receivables | 853M | 804M | 1.00B |
| Metric | 31/03/2026 | 31/12/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | 270M | — | — | 238M | — |
| Depreciation and amortisation | — | 25M | — |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 713M |
| 717M |
| 695M |
| 862M |
| 675M |
| Current assets | 1.50B | 1.39B | 1.38B | 1.09B | 1.13B | 1.08B | 1.30B | 1.09B |
| Property, plant and equipment | 55M | 57M | 61M | 65M | 68M | 71M | 75M | 78M |
| Goodwill | 3.40B | 3.41B | 3.49B | 3.50B | 3.44B | 3.42B | 3.46B | 3.44B |
| Total assets | 6.54B | 6.43B | 6.62B | 6.23B | 6.16B | 6.08B | 6.38B | 6.13B |
| Current liabilities | 1.22B | 1.14B | 1.24B | 1.23B | 1.15B | 1.56B | 1.67B | 1.57B |
| Short-term debt | 25M | 25M | 25M | 25M | 25M | 525M | 521M | 518M |
| Long-term debt | 1.17B | 1.17B | 1.17B | 1.21B | 1.36B | 1.02B | 1.23B | 1.29B |
| Total liabilities | 2.68B | 2.58B | 2.79B | 2.72B | 2.78B | 2.85B | 3.17B | 3.11B |
| Equity | 3.86B | 3.84B | 3.83B | 3.51B | 3.39B | 3.23B | 3.21B | 3.01B |
| Shares outstanding | 115M | 119M | 120M | 120M | 120M | 120M | 120M | 120M |
| Shares issued | 115M | 119M | 120M | 120M | 120M | 120M | 120M | 120M |
| 26M |
| — |
| Share-based compensation | 69M | 58M | 54M | 52M | 56M | 48M |
| Capital expenditure | — | 2M | — | — | 3M | — |
| Investing cash flow | — | 859,000 | — | — | 26M | — |
| Share buybacks | — | 200M | — | — | 75M | — |
| Financing cash flow | — | −244M | — | — | −324M | — |